Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of AMZ001 vs Diclofenac 1% Gel in Healthy Subjects
NCT05968482Phase 1Completed
- Sponsor
- Amzell B.V.
- Start
- Jul 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of diclofenac (AMZ001 formulation) in knee osteoarthritis (OA) (3 arms), sponsored by Amzell B.V. Primary endpoints: Exposure to Diclofenac at Day 7 and Maximum Plasma Concentration at Day 1. Started Jul 2023; status: completed.
02
Drugs
diclofenac (AMZ001 formulation)
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05968482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05968482.